Successful treatment of iatrogenic Kaposi's sarcoma with low-dose docetaxel therapy

J Dermatol. 2018 Apr;45(4):e96-e97. doi: 10.1111/1346-8138.14135. Epub 2017 Dec 7.

Authors

Atsushi Yamashiro¹, Ryoko Awazawa¹, Aoi Ohira¹, Tetsuo Hirata², Ryo Zamami³, Takuya Miyagi¹, Kenzo Takahashi¹

Affiliations

¹ Department of Dermatology, University of the Ryukyus, Graduate School of Medicine, Okinawa, Japan.
² Health Information Management Center, University of the Ryukyus Hospital, Okinawa, Japan.
³ Department of Cardiovascular Medicine, Nephrology and Neurology, University of the Ryukyus, Graduate School of Medicine, Okinawa, Japan.

PMID: 29215145
DOI: 10.1111/1346-8138.14135

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antineoplastic Agents / administration & dosage*
Antineoplastic Agents / therapeutic use*
Docetaxel / administration & dosage*
Docetaxel / therapeutic use*
Humans
Iatrogenic Disease
Immunosuppressive Agents / adverse effects
Japan
Male
Sarcoma, Kaposi / drug therapy*
Skin Neoplasms / drug therapy*
Taxoids / therapeutic use

Substances

Antineoplastic Agents
Immunosuppressive Agents
Taxoids
Docetaxel